Tarsus Pharmaceuticals, Inc. (TARS)
65.54
+2.27
(+3.59%)
USD |
NASDAQ |
Feb 19, 16:00
65.59
+0.05
(+0.08%)
After-Hours: 20:00
Tarsus Pharmaceuticals EPS Diluted (Quarterly) : -0.2954 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| BioMarin Pharmaceutical, Inc. | -0.1601 |
| Precigen, Inc. | -1.059 |
| Celcuity, Inc. | -0.9204 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Agenus, Inc. | 1.944 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -12.58M |
| Revenue (Quarterly) | 118.70M |
| Total Expenses (Quarterly) | 131.28M |
| Enterprise Value | 2.463B |
| Gross Profit Margin (Quarterly) | 93.00% |
| Profit Margin (Quarterly) | -10.60% |
| Earnings Yield | -3.07% |
| Normalized Earnings Yield | -3.072 |